Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ScripSolutions PBM Is “Sleeper” In Chronimed/MIM Merger

Executive Summary

The ScripSolutions PBM business may be poised for growth following the merger of MIM and Chronimed

You may also be interested in...



Average Sales Price Unveiled; IG Will Monitor Part B Market In 2005

The HHS Inspector General will monitor prices for drugs covered under Medicare Part B to determine whether the "average sales price" accurately reflects market prices once payment rates for 2005 are finalized this fall

DPS CONTRACTING SHIFT HELPS SB INCREASE PROFIT MARGINS BY 3.7 POINTS IN FIRST QUARTER; BLISSENBACH JOINS CHRONIMED AS PRESIDENT AND CHIEF OPERATING OFFICER

A change in contracting practices by SmithKline Beecham's DPS pharmacy benefit management business contributed 2.7 percentage points to the company's pharmaceutical business operating margins during the first quarter.

Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011

Topics

UsernamePublicRestriction

Register

PS044519

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel